B7-1 gene-modified autologous tumor cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B7-1 gene-modified autologous tumor cell vaccine, covering 2012-09-27 to 2012-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 [Phase 2]